Which brand of Crizotinib is more effective?

Crizotinib (Crizotinib) is an oral small molecule tyrosine kinase inhibitor (TKI), mainly used to treat AL Kpositive or ROS1positive non-small cell lung cancer (NSCLC) patients. It inhibits the activity of kinases such as ALK and ROS1 in cancer cells, thereby preventing the growth and spread of tumor cells. Crizotinib was originally developed by Pfizer (Pfizer) and launched the original drug Xalkori. Currently, there are multiple brands on the market, including the original drug and multiple generic versions.

Original brandXalkori The efficacy and safety of Xalkori have been confirmed by a large number of clinical studies. Its drug purity, release mechanism and bioavailability are relatively more guaranteed, and it is the first choice recommended by many doctors. However, the price of original drugs is relatively high, especially when it has not been included in local medical insurance or the reimbursement ratio of medical insurance is low, which puts a heavy financial burden on patients.

In recent years, pharmaceutical companies in many countries have also launched generic crizotinib drugs, such as IndiaNATCO, Laos Lucius and other brands, and the prices are generally more affordable. Although the efficacy of generic drugs is usually equivalent to that of original drugs, there may be certain differences in production standards, impurity control and drug stability. Therefore, it is particularly important to choose a generic drug brand from formal channels, with a good reputation and registered with the State Food and Drug Administration.

To sum up, if economic conditions permit or there are high requirements for efficacy and safety, it is recommended that the original brand Xalkori be the first choice; if you are more sensitive to price, you can consider overseas generic drugs with reliable quality. No matter which brand you choose, patients should ensure that the drug comes from a regular source and is used rationally under the guidance of a professional doctor.

Reference materials:https://go.drugbank.com/drugs/DB08865